glycopyrrolate has been researched along with fumarates in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 8 (88.89) | 2.80 |
| Authors | Studies |
|---|---|
| Dwivedi, SK; Joshi, V; Lechuga-Ballesteros, D; Noga, B; Vehring, R | 1 |
| Attri, S; Ballal, S; Darken, P; de Nigris, E; Ferguson, GT; Holmgren, U; Siddiqui, MK; Singh, B | 1 |
| Assam, PN; Dorinsky, P; Feng, C; Gillen, M; Huang, Y; Su, R | 1 |
| Bourdin, A; De Nigris, E; Ferguson, GT; Holmgren, U; Jenkins, M; Molinari, N; Ouwens, M; Siddiqui, MK; Singh, B | 1 |
| Nigro, SC; Sobieraj, DM | 1 |
| He, X; Liu, J; Wu, J | 1 |
| Effendi, WI; Emoto, N; Hazama, D; Katsurada, N; Kobayashi, K; Nagano, T; Nishimura, Y; Ryanto, GRT; Suraya, R; Tachihara, M; Yamamoto, M | 1 |
| Guerra, I; Lukyanov, V; Madoni, A; Magni, T; Orlovic, M | 1 |
| Aceituno, S; Baloira, A; Calvo, A; Garin, N; Martínez, A; Prades, M; Torres, C; Touron, C; Trigueros, JA | 1 |
4 review(s) available for glycopyrrolate and fumarates
| Article | Year |
|---|---|
Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-2 Receptor Agonists; Aged; Bayes Theorem; Bronchodilator Agents; Budesonide; Drug Combinations; Dyspnea; Female; Forced Expiratory Volume; Formoterol Fumarate; Fumarates; Glycopyrrolate; Humans; Male; Metered Dose Inhalers; Middle Aged; Muscarinic Agonists; Muscarinic Antagonists; Network Meta-Analysis; Pulmonary Disease, Chronic Obstructive; Respiratory Function Tests; Treatment Outcome | 2020 |
Efficacy and Safety of Budesonide/Glycopyrronium/Formoterol Fumarate versus Other Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis.
Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Bayes Theorem; Bronchodilator Agents; Budesonide; Drug Combinations; Formoterol Fumarate; Fumarates; Glycopyrrolate; Humans; Muscarinic Antagonists; Network Meta-Analysis; Pulmonary Disease, Chronic Obstructive; Quality of Life | 2021 |
Budesonide/Glycopyrrolate/Formoterol Fumarate Co-suspension Metered Dose Inhaler: A Triple Therapy for the Treatment of Chronic Obstructive Pulmonary Disease.
Topics: Bronchodilator Agents; Budesonide; Double-Blind Method; Drug Combinations; Formoterol Fumarate; Fumarates; Glycopyrrolate; Humans; Metered Dose Inhalers; Pulmonary Disease, Chronic Obstructive | 2022 |
Economic Evaluation of Triple Therapy with Budesonide/Glycopyrrolate/Formoterol Fumarate for the Treatment of Moderate to Very Severe Chronic Obstructive Pulmonary Disease in China Using a Semi-Markov Model.
Topics: Administration, Inhalation; Bronchodilator Agents; Budesonide; Clinical Studies as Topic; Cost-Benefit Analysis; Drug Combinations; Formoterol Fumarate; Fumarates; Glycopyrrolate; Humans; Metered Dose Inhalers; Pulmonary Disease, Chronic Obstructive | 2022 |
1 trial(s) available for glycopyrrolate and fumarates
| Article | Year |
|---|---|
Ethnic pharmacokinetic comparison of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler (BGF MDI) between Asian and Western healthy subjects.
Topics: Administration, Inhalation; Bronchodilator Agents; Budesonide; Double-Blind Method; Drug Combinations; Formoterol Fumarate; Fumarates; Glycopyrrolate; Healthy Volunteers; Humans; Metered Dose Inhalers; Pulmonary Disease, Chronic Obstructive | 2020 |
4 other study(ies) available for glycopyrrolate and fumarates
| Article | Year |
|---|---|
Cosuspensions of microcrystals and engineered microparticles for uniform and efficient delivery of respiratory therapeutics from pressurized metered dose inhalers.
Topics: Drug Delivery Systems; Ethanolamines; Formoterol Fumarate; Fumarates; Glycopyrrolate; Hydrocarbons, Fluorinated; Metered Dose Inhalers; Mometasone Furoate; Particle Size; Phospholipids; Porosity; Pregnadienediols; Respiratory Therapy; Solubility; Surface Properties; Water | 2012 |
Budesonide/glycopyrronium/formoterol fumarate triple therapy prevents pulmonary hypertension in a COPD mouse model via NFκB inactivation.
Topics: Animals; Bronchodilator Agents; Budesonide; Budesonide, Formoterol Fumarate Drug Combination; Emphysema; Endothelial Cells; Formoterol Fumarate; Fumarates; Glycopyrrolate; Hypertension, Pulmonary; Mice; NF-kappa B; Pancreatic Elastase; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema | 2022 |
Cost-effectiveness of single-inhaler extrafine beclometasone dipropionate/formoterol fumarate/glycopyrronium in patients with uncontrolled asthma in England.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adult; Asthma; Beclomethasone; Clinical Trials as Topic; Cost-Benefit Analysis; Drug Combinations; Formoterol Fumarate; Fumarates; Glycopyrrolate; Humans; Nebulizers and Vaporizers; State Medicine; Tiotropium Bromide | 2022 |
Cost-Effectiveness Analysis of Triple Therapy with Budesonide/ Glycopyrronium/ Formoterol Fumarate versus Dual Therapy in Patients with Chronic Obstructive Pulmonary Disease in Spain.
Topics: Bronchodilator Agents; Budesonide; Budesonide, Formoterol Fumarate Drug Combination; Cost-Benefit Analysis; Formoterol Fumarate; Fumarates; Glycopyrrolate; Humans; Pulmonary Disease, Chronic Obstructive; Spain | 2022 |